Aralez Pharmaceuticals Canada Inc. v. JAMP Pharma Corporation et al.

Call to arrange a consultation

2024

T-1608-24

Pending

8.2 PMNOC

Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,632,375 (diclofenac).

Counsel to:

JAMP Pharma Corporation

The decision is reported

Partner

Associate

Associate